Engineering

How ColdAI builds the technology behind Frida.

Schizophrenia Overview Psychosis & Episodes Medications Side Effects Famous People with Schizophrenia Patient Experiences CBT for Psychosis Hospitalisation & Crisis Lifestyle & Wellbeing For Families & Caregivers Engineering

The PANSS: how the Positive and Negative Syndrome Scale is used

If you have ever read a sentence like 'PANSS total decreased by 15 points,' this is the scale being described. The PANSS is the workhorse of antipsychotic trials, and the structure of its 30 items shapes how the field talks about schizophrenia.

The SAPS (Scale for the Assessment of Positive Symptoms)

Where the PANSS gives you 7 positive items, the SAPS gives you 34 — including detailed coverage of formal thought disorder. It remains the standard instrument when researchers want to look closely at positive symptoms.

How Frida tracks cognitive stability: a look under the hood

Frida turns short daily check-ins into a longitudinal picture of cognitive stability. Here is how it works, what it does not do, and why we built it this way.

The SANS (Scale for the Assessment of Negative Symptoms)

Negative symptoms are the hardest to measure because they are absences rather than presences. The SANS was the first scale that took them seriously, and it still anchors much of the field.

The BPRS (Brief Psychiatric Rating Scale)

Sixty years after it was first published, the BPRS is still in use because it is short, broad, and easy to teach. It is the rating scale equivalent of the screwdriver in the toolbox.

How we built Frida — a calm-tech approach to schizophrenia care

An engineering and product story about how Frida — a calm, evidence-informed schizophrenia stability app — is being built at ColdAI LLC.

The CGI (Clinical Global Impression) scale

The CGI takes thirty seconds and asks the clinician one question: how sick is this person, and how much have they changed? Its simplicity is exactly its strength.

Tracking early warning signs of relapse: what works

A relapse rarely arrives without warning. Sleep, energy, and routine usually shift days or weeks earlier. Tracking those shifts well is one of the highest-leverage things you can do.

Clinician scales used in research vs clinic

Trials use elaborate clinician-administered scales because precision is the whole point. Clinics need brevity and feasibility. The mismatch is solvable, but it has to be acknowledged.

Virtual reality for paranoia and social anxiety in schizophrenia

Putting on a headset to walk into a virtual coffee shop sounds gimmicky. The largest VR trial in schizophrenia to date suggests the effect is real for the right patient.

WSAS and other functional scales

Symptoms are not the same as life. Functional scales measure the things that actually matter to most people in recovery — work, relationships, household activities, leisure, and self-care.

AVATAR therapy: talking back to the voices

AVATAR therapy gives a face to the voice and lets the patient confront it directly. Two large UK trials suggest the effect is real, especially for distress.

Self-report scales for schizophrenia

Schizophrenia has historically been measured by clinicians, not patients. Newer self-report scales — CAPE, PQ-B, BAVQ-R, QPR — are changing that and giving patients a real seat at the measurement table.

Digital therapeutics for schizophrenia: what's FDA-cleared today

Digital therapeutics are software you can be prescribed. The category is small, the evidence is mixed, and the path to mainstream use has been bumpy.

Telepsychiatry for schizophrenia: outcomes after the COVID expansion

Telepsychiatry exploded in 2020 and has not contracted back. The evidence in schizophrenia is now substantial — and largely reassuring, with caveats.

Wearables for schizophrenia: what the data really show

Smartwatches, Fitbits and rings now produce huge volumes of data. Here's what's genuinely useful for schizophrenia, what's still research, and what to ignore.

The best apps for medication reminders in schizophrenia

Phone reminders are not magic — but for the right person, the right app can meaningfully reduce missed doses. Here's what the evidence supports.